HK Stock Movement | SHINEWAY PHARM (02877) Falls Over 2% in Afternoon Trading as Q3 Revenue Drops 16.3% YoY
Stock News
Nov 07
SHINEWAY PHARM (02877) declined over 2% in afternoon trading, dropping 2.14% to HKD 8.69 by the time of writing, with a turnover of HKD 5.3445 million. The company announced during the midday break that its unaudited management accounts for the nine months ended September 30, 2025, showed revenue of RMB 2.415 billion, down 16.3% year-on-year.
Breakdown of the revenue decline includes:
- Injectable products revenue fell 23.6% to RMB 786 million.
- Soft capsule products revenue dropped 13.7% to RMB 337 million.
- Granule products revenue decreased 14.5% to RMB 391 million.
- Traditional Chinese medicine formula granule products revenue declined 11.8% to RMB 726 million.
- Other dosage forms revenue slipped 6.1% to RMB 175 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.